SCHEMBL23537792

SCHEMBL23537792

C=CC(=O)N1CCC(Nc2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3n2)C1

nearest known ligand 0.70

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EGFR P00533 18/20 0.70
ERBB2 P04626 11/20 0.57
ERBB4 Q15303 3/20 0.57
JAK3 P52333 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23537790 1.00 EGFR (0.70) EGFRERBB2ERBB4JAK3
SCHEMBL23570910 0.96 EGFR (0.72) EGFRERBB2ERBB4JAK3
SCHEMBL23537739 0.90 EGFR (0.57) EGFRERBB2ERBB4
SCHEMBL23537738 0.90 EGFR (0.57) EGFRERBB2ERBB4
SCHEMBL23538180 0.89 EGFR (0.56) EGFRERBB2
SCHEMBL23538181 0.89 EGFR (0.56) EGFRERBB2
SCHEMBL23538057 0.88 EGFR (0.78) EGFRERBB2ERBB4JAK3
SCHEMBL23538059 0.88 EGFR (0.78) EGFRERBB2ERBB4JAK3
SCHEMBL23537942 0.86 EGFR (0.67) EGFRERBB2
SCHEMBL23537954 0.86 EGFR (0.72) EGFRERBB2ERBB4JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127397-A1 NITROGEN HETEROCYCLIC COMPOUNDS AND METHODS OF USE BLACK DIAMOND THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed
WO-2021127397-A1 NITROGEN HETEROCYCLIC COMPOUNDS AND METHODS OF USE BLACK DIAMOND THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed